Synlogic Inc Total Liabilities
Synlogic Inc total liabilities. Based on the latest financial reports, Synlogic Inc (SYBX) has total liabilities worth $3.58 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Synlogic Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Synlogic Inc (2013–2025)
Total liabilities of Synlogic Inc from 2013 to 2025. This chart illustrates how Synlogic Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Synlogic Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Synlogic Inc Competitors by Total Liabilities
The table below lists competitors of Synlogic Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hemostemix Inc
V:HEM
|
Canada | CA$4.80 Million |
|
Lantern Pharma Inc
NASDAQ:LTRN
|
USA | $11.82 Million |
|
Enlitic Inc
AU:ENL
|
Australia | AU$4.24 Million |
|
Pudjiadi Prestige Tbk
JK:PUDP
|
Indonesia | Rp43.27 Billion |
|
TEN Holdings, Inc. Common Stock
NASDAQ:XHLD
|
USA | $3.07 Million |
|
Advanced Medical Solutions Group plc
LSE:AMS
|
UK | GBX134.67 Million |
|
Auction Technology Group PLC
LSE:ATG
|
UK | GBX232.49 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down Synlogic Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Synlogic Inc total assets.
Liquidity & Leverage Metrics
Synlogic Inc Total Liabilities Ratios Explained
Synlogic Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Synlogic Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Synlogic Inc (2013–2025)
The table below shows the annual total liabilities of Synlogic Inc from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $3.58 Million | -49.34% |
| 2024-12-31 | $7.08 Million | -78.49% |
| 2023-12-31 | $32.90 Million | +16.42% |
| 2022-12-31 | $28.25 Million | +2.86% |
| 2021-12-31 | $27.47 Million | -4.30% |
| 2020-12-31 | $28.70 Million | -9.36% |
| 2019-12-31 | $31.67 Million | +94.98% |
| 2018-12-31 | $16.24 Million | +10.78% |
| 2017-12-31 | $14.66 Million | +284.40% |
| 2016-12-31 | $3.81 Million | -35.37% |
| 2015-12-31 | $5.90 Million | -89.79% |
| 2014-12-31 | $57.78 Million | +7.80% |
| 2013-12-31 | $53.60 Million | -- |
About Synlogic Inc
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.